Limitations for our study include that we could not include individual-level data such as HPV infection, smoking status, ART use, and other HIV disease markers (CD4 count and HIV viral load), and so, we can only hypothesize on how these and other covariates may affect the incidence and survival of anal cancer in our population. Here, CD4 is linked to anal carcinoma.